Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00289796
Status:
COMPLETED
Last Update Posted:
2017-02-08
First Post:
2006-02-09
Brief Title:
Assess Feasibility of an Acellular Pertussis Vaccine Pa Given Soon After Birth Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPVHib Vaccine
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
210602-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None